Barchart.com has highlighted two stocks from the Russell 2000 small-cap index that are rated as “strong buys” by Wall Street analysts and feature significant upside. Vaxcyte The biotech company Vaxcyte develops vaccines for infectious diseases, such as invasive pneumococcal infections, which include pneumococcal meningitis and bacteremia. While vaccines for these…